These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31416736)

  • 1. Clinical and functional change in multifocal motor neuropathy treated with IVIg.
    Chia PK; Hung SKY; Hiew FL
    J Clin Neurosci; 2019 Nov; 69():114-119. PubMed ID: 31416736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.
    Nobile-Orazio E; Cappellari A; Meucci N; Carpo M; Terenghi F; Bersano A; Priori A; Barbieri S; Scarlato G
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):761-6. PubMed ID: 12023421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.
    Van den Berg-Vos RM; Franssen H; Wokke JH; Van den Berg LH
    Brain; 2002 Aug; 125(Pt 8):1875-86. PubMed ID: 12135977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up.
    Baumann A; Hess CW; Sturzenegger M
    J Neurol; 2009 Apr; 256(4):608-14. PubMed ID: 19367358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
    Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
    Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
    Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
    Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.
    Vucic S; Black KR; Chong PS; Cros D
    Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
    Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
    J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?
    Simon NG; Ayer G; Lomen-Hoerth C
    Neurology; 2013 Dec; 81(24):2116-20. PubMed ID: 24212395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
    Chaudhry V; Cornblath DR
    J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.
    Cats EA; van der Pol WL; Piepers S; Franssen H; Jacobs BC; van den Berg-Vos RM; Kuks JB; van Doorn PA; van Engelen BG; Verschuuren JJ; Wokke JH; Veldink JH; van den Berg LH
    Neurology; 2010 Aug; 75(9):818-25. PubMed ID: 20805527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy.
    Rattay TW; Winter N; Décard BF; Dammeier NM; Härtig F; Ceanga M; Axer H; Grimm A
    Eur J Neurol; 2017 Sep; 24(9):1125-1134. PubMed ID: 28681489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.
    Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term follow up of multifocal motor neuropathy with conduction block under treatment.
    Azulay JP; Rihet P; Pouget J; Cador F; Blin O; Boucraut J; Serratrice G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):391-4. PubMed ID: 9120457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical definition of conduction block in IvIg responsive multifocal motor neuropathy.
    Ghosh A; Busby M; Kennett R; Mills K; Donaghy M
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1264-8. PubMed ID: 16107364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment.
    Slee M; Selvan A; Donaghy M
    Neurology; 2007 Oct; 69(17):1680-7. PubMed ID: 17954783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.
    Kuwabara S; Misawa S; Mori M; Iwai Y; Ochi K; Suzuki H; Nodera H; Tamaoka A; Iijima M; Toda T; Yoshikawa H; Kanda T; Sakamoto K; Kusunoki S; Sobue G; Kaji R;
    J Peripher Nerv Syst; 2018 Jun; 23(2):115-119. PubMed ID: 29635876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy.
    Ghosh A; Virgincar A; Kennett R; Busby M; Donaghy M
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1269-72. PubMed ID: 16107366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy.
    Nobile-Orazio E; Cocito D; Briani C; Plasmati R; Schenone A; Gallia F; Marjanovic I; Suffredini AL
    Neurol Sci; 2017 May; 38(5):899-902. PubMed ID: 28144763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.